» Articles » PMID: 38951230

The Role of the Radiologist in the Prostate Cancer Multidisciplinary Conference

Overview
Publisher Springer
Date 2024 Jul 1
PMID 38951230
Authors
Affiliations
Soon will be listed here.
Abstract

The broad range of disease aggressiveness together with imperfect screening, diagnostic, and treatment options in prostate cancer (PCa) makes medical decision-making complex. The primary goal of a multidisciplinary conference is to improve patient outcomes by combining evidence-based data and expert opinion to discuss optimal management, including for those patients with challenging presentations. The primary purpose of the genitourinary imaging specialist in the prostate cancer multidisciplinary conference is to use imaging findings to reduce uncertainty by answering clinical questions. In this review, we discuss the role and the opportunities for an imaging specialist to add value in the care of men with prostate cancer discussed at multidisciplinary conferences.

References
1.
Dawson N, Arkes H . Systematic errors in medical decision making: judgment limitations. J Gen Intern Med. 1987; 2(3):183-7. DOI: 10.1007/BF02596149. View

2.
Redelmeier D, Rozin P, Kahneman D . Understanding patients' decisions. Cognitive and emotional perspectives. JAMA. 1993; 270(1):72-6. View

3.
Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R . Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023; 21(10):1067-1096. DOI: 10.6004/jnccn.2023.0050. View

4.
Spinks T, Albright H, Feeley T, Walters R, Burke T, Aloia T . Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2011; 118(10):2571-82. PMC: 3272132. DOI: 10.1002/cncr.26536. View

5.
Pillay B, Wootten A, Crowe H, Corcoran N, Tran B, Bowden P . The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2015; 42:56-72. DOI: 10.1016/j.ctrv.2015.11.007. View